Follow The Filings

OSW

Earnings company data as of 6:45 AM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.29 — —
Rev — — —

Insider trades

Open-market buys and sales by OSW's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OSW insider trades
  • None no insider bought on the open market
  • $8.2M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Andrew R Heyer Director
    Sale
    $1.6M 60,000 shares at $26.40
    Traded Aug 6–10 Filed Aug 10
  2. Andrew R Heyer Director
    Sale
    $521K 20,000 shares at $26.04 3.9% of stake
    Traded Jun 15 Filed Jun 17
  3. Walter Field McLallen Director
    Sale
    $259K 10,500 shares at $24.67 7.1% of stake
    Traded Jun 11 Filed Jun 12
  4. Leonard I Fluxman See Remarks
    Sale
    $1.4M 58,642 shares at $24.14 5% of stake
    Traded Jun 8 Filed Jun 9
  5. Leonard I Fluxman See Remarks
    Sale
    $2.2M 89,986 shares at $24.06 7.2% of stake
    Traded Jun 3–5 Filed Jun 5
  6. Leonard I Fluxman See Remarks
    Sale
    $1.1M 42,883 shares at $24.56 3.3% of stake
    Traded May 27 Filed May 29
  7. Leonard I Fluxman See Remarks
    Sale
    $214K 8,489 shares at $25.26 0.6% of stake
    Traded May 7 Filed May 11
  8. Walter Field McLallen Director
    Sale
    $125K 6,000 shares at $20.86 3.9% of stake
    Traded Mar 11 Filed Mar 13
  9. Walter Field McLallen Director
    Sale
    $101K 5,000 shares at $20.21 3.1% of stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
  10. Stephen Lazarus CEO
    Sale
    $181K 8,569 shares at $21.12 2.4% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  11. Andrew R Heyer Director
    Sale
    $404K 20,000 shares at $20.19 3.8% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  12. Leonard I Fluxman See Remarks
    Sale
    $207K 10,282 shares at $20.12 0.9% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants, 4 other transactions, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 5.07
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
DEF 14A
SCHEDULE 13G/A —
DEFA14A
10-K
8-K 2.02,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.